DrugBank 4.0: shedding new light on drug metabolism
By V. Law, Craig Knox, Yannick Djoumbou, Timothy Jewison, Anchi Guo, Yifeng Liu, Adam Maciejewski, David Arndt, Michael Wilson, V. Neveu and 8 more. 2013
1,970 citations recorded by the source corpus.
DrugBank (http://www.drugbank.ca) is a comprehensive online database containing extensive biochemical and pharmacological information about drugs, their mechanisms and their targets. Since it was first described in 2006, DrugBank has rapidly evolved, both in response to user requests and in response to changing trends in drug research and development. Previous versions of DrugBank have been widely used to facilitate drug and in silico drug target discovery. The latest update, DrugBank 4.0, has been further expanded to contain data on drug metabolism, absorption, distribution, metabolism, excretion and toxicity (ADMET) and other kinds of quantitative structure activity relationships (QSAR) information. These enhancements are intended to facilitate research in xenobiotic metabolism (both prediction and characterization), pharmacokinetics, pharmacodynamics and drug design/discovery. For this release, >1200 drug metabolites (including their structures, names, activity, abundance and other detailed data) have been added along with >1300 drug metabolism reactions (including metabolizing enzymes and reaction types) and dozens of drug metabolism pathways. Another 30 predicted or measured ADMET parameters have been added to each DrugCard, bringing the average number of quantitative ADMET values for Food and Drug Administration-approved drugs close to 40. Referential nuclear magnetic resonance and MS spectra have been added for almost 400 drugs as well as spectral and mass matching tools to facilitate compound identification. This expanded collection of drug information is complemented by a number of new or improved search tools, including one that provides a simple analyses of drug–target, –enzyme and –transporter associations to provide insight on drug–drug interactions.
Subfields: Computational Theory and Mathematics, Molecular Biology, Spectroscopy, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Evan E. Bolton
- Stephen H. Bryant
- Sunghwan Kim
- José Miguel Hernández-Lobato
- Jure Leskovec
- Marinka Zitnik
- Alán Aspuru-Guzik
- Lianyi Han
In Molecular Biology
- Jure Leskovec
- Peer Bork
- Marinka Zitnik
- David S. Wishart
- Lars Juhl Jensen
- Stephen H. Bryant
- C. von Mering
- Sunghwan Kim
In Spectroscopy
- Evan E. Bolton
- Sunghwan Kim
- Stephen H. Bryant
- Peer Bork
- Bo Yu
- Lianyi Han
- C. von Mering
- Lars Juhl Jensen
In Computational Chemistry & Drug Discovery
- José Miguel Hernández-Lobato
- Alán Aspuru-Guzik
- Jan A. Kors
- Saber Ahmad Akhondi
- Sorel Muresan
- Michael Kuhn
- Peer Bork
- Rafael Gómez‐Bombarelli
Citations in the corpus
- Prioritizing network communities (2018, background): “Another drug with unanticipated community assignment is minaprine, a psychotropic drug that is effective in the treatment of various depressive states 23 .”
- Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules (2016, background): “In addition, a set of compounds from the list of 1386 FDA approved drugs were selected at random, [33] and subject to the same stochastic encode-decode process (Figures 6 and 7).”
- PubChem Substance and Compound databases (2015, methodology): “In addition, through integration with data from DrugBank (9), the Hazardous Substances Data Bank (10) and other databases, the annotation of chemical records includes pharmacology, drug target information, toxicology, safety and handling information.”
- The Transporter Classification Database (TCDB): recent advances (2015, background): “Entrez Gene ID (35) Information about the protein’s gene context can be viewed DrugBank (36) Known drug information related to a transporter can be accessed DIP (37) Database of Interacting Proteins indicates other proteins that may interact with a transporter HEGENOM Phylogenetic trees related to a”
- Ambiguity of non-systematic chemical identifiers within and between small-molecule databases (2015, background): “During production and maintenance all synonyms and brand names within DrugBank are extensively reviewed and only the most common synonyms are kept [31].”
- Data Fusion by Matrix Factorization (2013, methodology): “The data included 1;260 chemicals extracted from the complete DrugBank [66] database (accessed in Feb.”
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures (2015, background): “Fluorine atom Count Integer Toxicophore [1-36]c Binary vector Pharmacophore countd Integer vector a Topological polar surface area(23).”
- BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology (2015, background): “The second is a tabbed page of ‘Impor-tant Compounds’ in simplified format (www.bindingdb.org/ ByLigandName), with separate tabs providing information, drawn from BindingDB, DrugBank, ZINC, PubChem and other sources, for existing drugs, experimental drugs, other bioactive compounds of interest and p”
- STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data (2015, background): “A large part of the known interactions comes from manually curated datasets such as DrugBank (19), GPCR-ligand database (GLIDA) (20), Matador (21), the Therapeutic Targets Database (TTD) (22) and the Comparative Toxicogenomics Database (CTD) (23), and several pathway databases including the Kyoto En”
- Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC) (2017, methodology): “Moreover, we compared the molecules generated during training with the list of FDA-approved drugs [42], and found 148 coincidences for the chemical beauty and 207 for the Lipinski’s rule-of-five experiments; these include popular compounds, such as salicylic acid, benzocaine, paracetamol or…”
- Network-based prediction of drug combinations (2019, background): “3) 40 , the Therapeutic Target Database (TTD, v4.”